Literature DB >> 23344255

Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion.

Stephanie Duguez1, William Duddy, Helen Johnston, Jeanne Lainé, Marie Catherine Le Bihan, Kristy J Brown, Anne Bigot, Yetrib Hathout, Gillian Butler-Browne, Terence Partridge.   

Abstract

Duchenne muscular dystrophy results from loss of the protein dystrophin, which links the intracellular cytoskeletal network with the extracellular matrix, but deficiency in this function does not fully explain the onset or progression of the disease. While some intracellular events involved in the degeneration of dystrophin-deficient muscle fibers have been well characterized, changes in their secretory profile are undescribed. To analyze the secretome profile of mdx myotubes independently of myonecrosis, we labeled the proteins of mdx and wild-type myotubes with stable isotope-labeled amino acids (SILAC), finding marked enrichment of vesicular markers in the mdx secretome. These included the lysosomal-associated membrane protein, LAMP1, that co-localized in vesicles with an over-secreted cytoskeletal protein, myosin light chain 1. These LAMP1/MLC1-3-positive vesicles accumulated in the cytosol of mdx myotubes and were secreted into the culture medium in a range of abnormal densities. Restitution of dystrophin expression, by exon skipping, to some 30 % of the control value, partially normalized the secretome profile and the excess LAMP1 accumulation. Together, our results suggest that a lack of dystrophin leads to a general dysregulation of vesicle trafficking. We hypothesize that disturbance of the export of proteins through vesicles occurs before, and then concurrently with, the myonecrotic cascade and contributes chronically to the pathophysiology of DMD, thereby presenting us with a range of new potential therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23344255     DOI: 10.1007/s00018-012-1248-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  72 in total

Review 1.  Potential subversion of autophagosomal pathway by picornaviruses.

Authors:  Matthew P Taylor; Karla Kirkegaard
Journal:  Autophagy       Date:  2007-12-05       Impact factor: 16.016

2.  Colchicine myopathy: a vacuolar myopathy with selective type I muscle fiber involvement. An immunohistochemical and electron microscopic study of two cases.

Authors:  C Fernandez; D Figarella-Branger; P Alla; J-R Harlé; J-F Pellissier
Journal:  Acta Neuropathol       Date:  2001-12-01       Impact factor: 17.088

3.  Culturing satellite cells from living single muscle fiber explants.

Authors:  J D Rosenblatt; A I Lunt; D J Parry; T A Partridge
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-11       Impact factor: 2.416

4.  Oxidative damage to muscle protein in Duchenne muscular dystrophy.

Authors:  J W Haycock; S MacNeil; P Jones; J B Harris; D Mantle
Journal:  Neuroreport       Date:  1996-12-20       Impact factor: 1.837

5.  Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease).

Authors:  I Nishino; J Fu; K Tanji; T Yamada; S Shimojo; T Koori; M Mora; J E Riggs; S J Oh; Y Koga; C M Sue; A Yamamoto; N Murakami; S Shanske; E Byrne; E Bonilla; I Nonaka; S DiMauro; M Hirano
Journal:  Nature       Date:  2000-08-24       Impact factor: 49.962

Review 6.  The role of free radicals in the pathophysiology of muscular dystrophy.

Authors:  James G Tidball; Michelle Wehling-Henricks
Journal:  J Appl Physiol (1985)       Date:  2006-11-09

Review 7.  Pathophysiology of duchenne muscular dystrophy: current hypotheses.

Authors:  Nicolas Deconinck; Bernard Dan
Journal:  Pediatr Neurol       Date:  2007-01       Impact factor: 3.372

8.  Reciprocal amplification of ROS and Ca(2+) signals in stressed mdx dystrophic skeletal muscle fibers.

Authors:  Vyacheslav M Shkryl; Adriano S Martins; Nina D Ullrich; Martha C Nowycky; Ernst Niggli; Natalia Shirokova
Journal:  Pflugers Arch       Date:  2009-04-22       Impact factor: 3.657

9.  Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state.

Authors:  M H Disatnik; J Dhawan; Y Yu; M F Beal; M M Whirl; A A Franco; T A Rando
Journal:  J Neurol Sci       Date:  1998-11-26       Impact factor: 3.181

10.  Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm.

Authors:  Philip Doran; Steve D Wilton; Sue Fletcher; Kay Ohlendieck
Journal:  Proteomics       Date:  2009-02       Impact factor: 3.984

View more
  24 in total

1.  Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients.

Authors:  Yetrib Hathout; Ramya L Marathi; Sree Rayavarapu; Aiping Zhang; Kristy J Brown; Haeri Seol; Heather Gordish-Dressman; Sebahattin Cirak; Luca Bello; Kanneboyina Nagaraju; Terry Partridge; Eric P Hoffman; Shin'ichi Takeda; Jean K Mah; Erik Henricson; Craig McDonald
Journal:  Hum Mol Genet       Date:  2014-07-15       Impact factor: 6.150

2.  β-Arrestin scaffolds and signaling elements essential for the obestatin/GPR39 system that determine the myogenic program in human myoblast cells.

Authors:  Icía Santos-Zas; Uxía Gurriarán-Rodríguez; Tania Cid-Díaz; Gabriela Figueroa; Jessica González-Sánchez; Mónica Bouzo-Lorenzo; Carlos S Mosteiro; José Señarís; Felipe F Casanueva; Xesús Casabiell; Rosalía Gallego; Yolanda Pazos; Vincent Mouly; Jesús P Camiña
Journal:  Cell Mol Life Sci       Date:  2015-07-27       Impact factor: 9.261

Review 3.  Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.

Authors:  David G Allen; Nicholas P Whitehead; Stanley C Froehner
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

4.  204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24-26 January 2014, Naarden, The Netherlands.

Authors:  Alessandra Ferlini; Kevin M Flanigan; Hanns Lochmuller; Francesco Muntoni; Peter A C 't Hoen; Elizabeth McNally
Journal:  Neuromuscul Disord       Date:  2014-09-11       Impact factor: 4.296

Review 5.  Histopathology of Duchenne muscular dystrophy in correlation with changes in proteomic biomarkers.

Authors:  Margit Zweyer; Hemmen Sabir; Paul Dowling; Stephen Gargan; Sandra Murphy; Dieter Swandulla; Kay Ohlendieck
Journal:  Histol Histopathol       Date:  2021-12-07       Impact factor: 2.303

6.  Simultaneous Pathoproteomic Evaluation of the Dystrophin-Glycoprotein Complex and Secondary Changes in the mdx-4cv Mouse Model of Duchenne Muscular Dystrophy.

Authors:  Sandra Murphy; Michael Henry; Paula Meleady; Margit Zweyer; Rustam R Mundegar; Dieter Swandulla; Kay Ohlendieck
Journal:  Biology (Basel)       Date:  2015-06-10

7.  Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies.

Authors:  Jérémy Rouillon; Jérôme Poupiot; Aleksandar Zocevic; Fatima Amor; Thibaut Léger; Camille Garcia; Jean-Michel Camadro; Brenda Wong; Robin Pinilla; Jérémie Cosette; Anna M L Coenen-Stass; Graham Mcclorey; Thomas C Roberts; Matthew J A Wood; Laurent Servais; Bjarne Udd; Thomas Voit; Isabelle Richard; Fedor Svinartchouk
Journal:  Hum Mol Genet       Date:  2015-06-09       Impact factor: 6.150

8.  Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia.

Authors:  William Duddy; Stephanie Duguez; Helen Johnston; Tatiana V Cohen; Aditi Phadke; Heather Gordish-Dressman; Kanneboyina Nagaraju; Viola Gnocchi; SiewHui Low; Terence Partridge
Journal:  Skelet Muscle       Date:  2015-05-01       Impact factor: 4.912

9.  Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies.

Authors:  Burcu Ayoglu; Amina Chaouch; Hanns Lochmüller; Luisa Politano; Enrico Bertini; Pietro Spitali; Monika Hiller; Eric H Niks; Francesca Gualandi; Fredrik Pontén; Kate Bushby; Annemieke Aartsma-Rus; Elena Schwartz; Yannick Le Priol; Volker Straub; Mathias Uhlén; Sebahattin Cirak; Peter A C 't Hoen; Francesco Muntoni; Alessandra Ferlini; Jochen M Schwenk; Peter Nilsson; Cristina Al-Khalili Szigyarto
Journal:  EMBO Mol Med       Date:  2014-07       Impact factor: 12.137

10.  Application of fluorescence two-dimensional difference in-gel electrophoresis as a proteomic biomarker discovery tool in muscular dystrophy research.

Authors:  Steven Carberry; Margit Zweyer; Dieter Swandulla; Kay Ohlendieck
Journal:  Biology (Basel)       Date:  2013-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.